Emmanuel Hanon, Founder of Vicebio

Emmanuel Hanon is the founder of Vicebio. Vicebio has raised $100M in total funding. Latest round: Series B. Based in London, UK.

About Emmanuel Hanon

Emmanuel Hanon is the CEO of Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections. He leads the company in leveraging its proprietary Molecular Clamp technology to create next-generation multivalent respiratory virus vaccines.

Emmanuel Hanon at a glance

More founders in London, UK (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library